Tuesday, November 24, 2009

COPD Home>
COPD News>
FDA asks for more info on COPD drug

Font size
- A
- A
- A
Email This

Bookmark

Save

Are you an asthma sufferer? Manage your asthma or COPD with great ideas from people like you.Start here.

FDA asks for more info on COPD drug

(ABC News) UPDATED 2009-10-19

The U.S. Food and Drug Administration has asked drugmaker Novartis for more data on their experimental COPD medication. The drug--known as QAB149, or indacaterol--is a once-daily bronchodilator for patients who have emphysema or chronic bronchitis. The drug was recently approved in Europe, and a drugmaker spokesperson said the company felt confident it could address the FDA's concerns. Read full story >

See all COPD News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on COPDConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.